TrialBlood2018

Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma.

Christoph Driessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.